Orthox

Orthox develops medical devices using FibroFix, a proprietary technology based on purified silk protein fibroin, to treat cartilage injuries. The company's lead product, FibroFix Cartilage, is designed to repair and regenerate shock-absorbing meniscal cartilage in the knee through a minimally invasive surgical procedure. These implants provide immediate functional replacement while supporting the long-term regrowth of the patient's own tissue to prevent the development of osteoarthritis.